Research Overview: Tamoxifen Citrate Investigation
Tamoxifen Citrate is a selective estrogen receptor modulator (SERM) that functions as a competitive antagonist at estrogen receptors in various tissue types. This Hilma Biocare formulation delivers 20mg of pharmaceutical-grade tamoxifen citrate per tablet, enabling precise dosing control for laboratory research protocols. Research institutions frequently investigate this compound’s interactions with estrogen pathways, particularly its selective tissue-specific effects. Scientists at Stroid UK Shop examine how tamoxifen citrate modulates estrogen receptor activity across different cellular environments. The compound’s unique pharmacological profile makes it valuable for studying hormonal regulation mechanisms and receptor-mediated cellular responses.
Laboratory Research Applications
Research applications for tamoxifen citrate span multiple scientific domains, including endocrinology, oncology research, and receptor pharmacology studies. Laboratory investigations examine its competitive binding affinity for estrogen receptors, particularly its differential effects in various tissue types. Scientists study how tamoxifen citrate influences cellular proliferation pathways and gene expression patterns related to estrogen signalling. Comparative studies with other selective estrogen receptor modulators help researchers understand structure-activity relationships within this compound class. Advanced research protocols evaluate tamoxifen’s metabolic pathways and its active metabolite formation. Researchers often incorporate tamoxifen citrate studies alongside investigations into selective androgen receptor modulators and peptide hormones to examine cross-pathway interactions in hormonal regulation research.
Technical Specifications
| Active Compound | Tamoxifen Citrate |
|---|---|
| Concentration | 20mg per tablet |
| Manufacturer | Hilma Biocare |
| Chemical Formula | C₂₆H₂₉NO₂·C₆H₈O₇ |
| Molecular Weight | 563.64 g/mol |
| CAS Number | 54965-24-1 |
| Storage Requirements | Cool, dry conditions below 25°C |
Research Compliance Statement
This Tamoxifen Citrate 20mg product is manufactured by Hilma Biocare exclusively for in-vitro laboratory research purposes. This compound is not intended for human consumption, clinical application, or therapeutic use. Researchers must maintain appropriate laboratory protocols and safety measures when handling this material. All studies should comply with institutional research guidelines and applicable regulations governing laboratory research chemicals.
